Tuesday, 3 November 2026
M
Meridian Globe
Live briefing
Oriental Kopi founder wants to put Malaysia on the menu— 日经 Nikkei AsiaIndonesian political maneuvers hinder market reforms amid downgrade threats— 日经 Nikkei AsiaChinese Communist Party taps big data surveillance to combat corruption— 日经 Nikkei AsiaJapan is attracting startups. But can it keep them?— 日经 Nikkei AsiaMitsubishi Heavy gears up to boost US gas turbine production— 日经 Nikkei AsiaNuclear reactors under construction rise to 79 globally on AI demand— 日经 Nikkei AsiaMyanmar refugees fill labor gaps in Thailand as Cambodians return home— 日经 Nikkei AsiaCyber insurance inquiries surge at Japan's nonlife insurers— 日经 Nikkei AsiaOriental Kopi founder wants to put Malaysia on the menu— 日经 Nikkei AsiaIndonesian political maneuvers hinder market reforms amid downgrade threats— 日经 Nikkei AsiaChinese Communist Party taps big data surveillance to combat corruption— 日经 Nikkei AsiaJapan is attracting startups. But can it keep them?— 日经 Nikkei AsiaMitsubishi Heavy gears up to boost US gas turbine production— 日经 Nikkei AsiaNuclear reactors under construction rise to 79 globally on AI demand— 日经 Nikkei AsiaMyanmar refugees fill labor gaps in Thailand as Cambodians return home— 日经 Nikkei AsiaCyber insurance inquiries surge at Japan's nonlife insurers— 日经 Nikkei Asia

Clinical risk factors alone do not predict the development of moderate-severe chronic graft-versus-host disease after hematopoietic cell transplantation and post-transplant cyclophosphamide

Source Nature 医学研究4d ago
Summary

We index headlines and summaries only. Full content and copyright remain with the original publisher — follow the source link to read it.

Open original
Desk
Health
Region
Global
Language
English
Item ID
health-fcc17639

Comments 0 comments

No comments yet. Be the first.

Clinical risk factors alone do not predict the development of moderate-severe chronic graft-versus-host disease after hematopoietic cell transplantation and post-transplant cyclophosphamide · Meridian Globe